Companies: 10,795·Total market cap: $144.5T
Evome Medical Technologies Inc.

Evome Medical Technologies Inc.

LNDZFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$5981
P/E Ratio—
52W High$0.006
52W Low$0.0001
SEC Filings

Evome Medical Technologies Inc. (LNDZF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001617765 · LNDZF · OTC · as of Jun 10, 2026

Filing snapshot

114
Total Filings
6-K
Latest Form
2024-12-05
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001617765 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-04-16
Fiscal Year End
Apr 16, 2024
Accession No.
0001062993-24-008449
Primary Document
form10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001617765 · Accession 0001062993-24-008449

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2023-11-14
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2024-04-15Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-12-05
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-11-13
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-08-15
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-08-13
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-07-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-06-17
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-06-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-06-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-05-31
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-04-23
View
10-KAnnual Report
FORM 10-K
2024-04-16
View
8-KCurrent Report
FORM 8-K
2024-04-15
View
8-KCurrent Report
FORM 8-K
2024-04-04
View
8-KCurrent Report
FORM 8-K
2024-04-01
View
NT 10-KNT 10-K
FORM NT 10-K
2024-04-01
View
Showing 1–15 of 110 filingsForm 4 / 144 hidden· 114 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001617765  |  Exchange: OTC · Healthcare

Evome Medical Technologies Inc. (OTC: LNDZF) has submitted 114 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001617765, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Evome Medical Technologies Inc.'s most comprehensive regulatory disclosure. The most recent Evome Medical Technologies Inc. 10-K was filed on 2024-04-16 for fiscal year ending 2024. Historical LNDZF 10-K annual reports are available from 2014 through 2024.

Investors researching Evome Medical Technologies Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
OSA SEC Filings →FLURF SEC Filings →ALSE SEC Filings →ACHKF SEC Filings →PLSI SEC Filings →NHIQ SEC Filings →VEGGD SEC Filings →SNDD SEC Filings →
→ LNDZF Financials→ LNDZF Earnings→ LNDZF Insider Trades

Frequently Asked Questions

LNDZF SEC Filings · 8 questions

Evome Medical Technologies Inc. (LNDZF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 114 filings and access original documents at no cost. Evome Medical Technologies Inc.'s CIK is 0001617765.

LNDZF SEC filingsEvome Medical Technologies Inc. SEC documentsfind LNDZF 10-K